AQST
NASDAQ
$3.95
Aquestive Therapeutics Inc (AQST)
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and internationally. The company is headquartered in Warren, New Jersey.
Sector:
Healthcare
Strong Buy
Target: $8.89 (+125.35%)
Market Cap
$491M
Free Cash Flow Yield
-9.03%
Beta (5Y)
1.37
Price Chart
Valuation
Market Cap$491M
P/S9.86
P/B14.15
Profitability
Total Revenue (TTM)$50M
Gross Profit (TTM)$32M
EBITDA-$55M
Profit Margin-55.8%
Operating Margin-29.1%
EPS-$0.59
Financial Health
Debt-to-Equity-132.1%
Free Cash Flow Yield-9.03%
Growth & Risk
EPS 5Y CAGR-17.65%
Revenue 5Y CAGR+0.84%
FCF 5Y CAGR-0.92%
Beta (5Y)1.37
Sharpe Ratio0.26